Livingston, NJNCT07563881Now EnrollingIRB Ready

Focal Seizure Clinical Trial in Livingston, NJ

Access cutting-edge focal seizure treatment through this phase 3 clinical trial at a research site in Livingston. Study-provided care at no cost to qualified participants.

Sponsored by Rapport Therapeutics Inc.

Quick Self-Assessment

See if you qualify for this Livingston location

Preparing your pre-screening questions…

Expert Care in Livingston

Access focal seizure specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related focal seizure treatment provided free

Apply for This Livingston Location

Check if you qualify for this focal seizure clinical trial in Livingston, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Livingston

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Livingston site if eligible
  4. 4Begin participation

About This Focal Seizure Study in Livingston

This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.

Sponsor: Rapport Therapeutics Inc.

Who Can Participate

Inclusion Criteria

Age 18 - 75
BMI 18-45 kg/m2
Diagnosis of focal epilepsy for ≥24 months prior to Visit 1
Report from at least 1 brain MRI or CT scan and 1 EEG study, each completed within 10 years prior to Visit 1, consistent with focal epilepsy diagnosis
Concomitant use of between 1 and 3, inclusive, antiseizure medication(s) ASM(s) as maintenance, not including rescue or pro re nata (PRN) ASMs
Ability to keep accurate daily focal seizure records using an e-diary

Exclusion Criteria

Known hypersensitivity or prior exposure to RAP-219.
Unstable or uncontrolled serious medical, neurologic (other than focal epilepsy), or psychiatric condition that is ongoing or considered likely to recur
Anticipated need for surgery during the study period
Medical history of any of the following:
generalized epilepsy
focal preserved consciousness without observable manifestations (also known as focal aware nonmotor) as the participant's only seizure type
psychogenic nonepileptic seizure (PNES)
status epilepticus or seizure clusters (when individual seizures cannot be counted) within 12 months prior to Visit 1 (Day -56).
epilepsy surgery within 12 months prior to Visit 1 (Day -56).
Participation in another clinical study of an investigational product within 12 weeks or 5 half-lives of this other investigational product

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Livingston?

Yes, this clinical trial (NCT07563881) has an active research site in Livingston, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Focal Seizure Treatment Options in Livingston, NJ

If you're searching for focal seizure treatment options in Livingston, NJ, this clinical trial (NCT07563881) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Livingston research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced focal seizure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all focal seizure clinical trials near you to find additional studies recruiting in your area.

More Epilepsy Trials in Livingston, NJ

See all epilepsy clinical trials recruiting in Livingston — not just this study.

Browse Epilepsy Trials in Livingston →

Browse More Trials by Condition

Epilepsy TrialsAll Conditions →

Ready to Join in Livingston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Livingston, NJ